Get started
Author

Elisa Nada

Observed names: E Nada, E. NADA, E. Nada
Observed institutions: University of Verona, University of Parma, Azienda Ospedaliera Universitaria Integrata Verona, Chiesi (Germany), Ospedale Maggiore di Chieri, Regione Piemonte
ORCID: 0000-0002-0765-5208
Observed ORCID: 0000-0002-0765-5208
OpenAlex ID: A5071855267
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
2017 · Olga Vaccaro, Maria Masulli, et al. · The Lancet Diabetes & Endocrinology · 297
Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study
2019 · Maria Chiara Rossi, Antonio Nicolucci, et al. · Nutrition Metabolism and Cardiovascular Diseases · 144
Sexual Dysfunction at the Onset of Type 2 Diabetes: The Interplay of Depression, Hormonal and Cardiovascular Factors
2014 · Giovanni Corona, Carlo B. Giorda, et al. · The Journal of Sexual Medicine · 138
Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature
2014 · Carlo B. Giorda, Elisa Nada, et al. · Endocrine · 88
Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies
2014 · Carlo B. Giorda, Carlotta Sacerdote, et al. · Endocrine · 72
The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.
2013 · G Corona, C B Giorda, et al. · PubMed · 55
The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes
2012 · Carlo Giorda, Roberta Picariello, et al. · PLoS ONE · 53
PDF
Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin
2007 · V. EVANGELISTA, G. DE BERARDIS, et al. · Journal of Thrombosis and Haemostasis · 39
PDF
Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study
2013 · Carlo B Giorda, Roberta Picariello, et al. · The Lancet Diabetes & Endocrinology · 37
Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors
2016 · Giovanni Corona, Carlo B. Giorda, et al. · PLoS ONE · 32
PDF
A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position
2014 · C. B. Giorda, E. Nada, et al. · Diabetes Obesity and Metabolism · 26
Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study
2024 · Carlo B. Giorda, Roberta Picariello, et al. · Diabetes Research and Clinical Practice · 17
Hepatocellular carcinoma in a large cohort of type 2 diabetes patients
2023 · Carlo B. Giorda, Roberta Picariello, et al. · Diabetes Research and Clinical Practice · 15
Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes
2019 · Carlo B. Giorda, Roberta Picariello, et al. · Acta Diabetologica · 15
Comparison of direct costs of type 2 diabetes care: Different care models with different outcomes
2014 · C.B. Giorda, R. Picariello, et al. · Nutrition Metabolism and Cardiovascular Diseases · 13
Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application
2023 · A. Piatti, F. Romeo, et al. · Acta Diabetologica · 12
Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial
2020 · Giovanni Cioffi, Carlo Bruno Giorda, et al. · European Journal of Preventive Cardiology · 12
Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading
2024 · A. Piatti, C. Rui, et al. · European Journal of Ophthalmology · 10
From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression
2021 · Carlo Bruno Giorda, Roberta Picariello, et al. · Diabetes Research and Clinical Practice · 9
PDF
Hepatic fibrosis of any origin in a large population of type 2 diabetes patients
2021 · Carlo B. Giorda, Roberta Picariello, et al. · Nutrition Metabolism and Cardiovascular Diseases · 7
Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study
2015 · on behalf of the ACCADEMY Study Group, Carlo B. Giorda, et al. · Endocrine · 7
Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting
2012 · C. B. Giorda, M. F. Mulas, et al. · Acta Diabetologica · 5
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population
2019 · on behalf of DYDA 2 Investigators, Carlo Bruno Giorda, et al. · Cardiovascular Drugs and Therapy · 4
PDF
Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic
2022 · Carlo B Giorda, Roberta Picariello, et al. · Acta Diabetologica · 3
PDF
Erratum to: Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature
2014 · Carlo B. Giorda, Elisa Nada, et al. · Endocrine · 3
PDF
Works count: 26
Citation count: 1,114
H-index: 14
I10-index: 18
Year
Topic
Type